
Here's Why You Should Hold Lantheus (LNTH) in Your Portfolio Now
Lantheus' (LNTH) focus on pipeline development raises optimism about the stock.

Here's Why Lantheus Holdings (LNTH) Gained But Lagged the Market Today
The latest trading day saw Lantheus Holdings (LNTH) settling at $65.56, representing a +0.55% change from its previous close.

Factors Setting the Tone For Lantheus' (LNTH) Q1 Earnings
Lantheus' (LNTH) first-quarter results are likely to reflect solid top-line performance on the back of robust product adoption.

Here's Why Lantheus Holdings (LNTH) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Lantheus Holdings (LNTH) Beats Stock Market Upswing: What Investors Need to Know
Lantheus Holdings (LNTH) reachead $60.42 at the closing of the latest trading day, reflecting a +1.14% change compared to its last close.

5 Medical Product Stocks to Buy Amid Industry Challenges
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, RMD, ZBH, PODD and LNTH are well-...

Lantheus Holdings (LNTH) Registers a Bigger Fall Than the Market: Important Facts to Note
In the most recent trading session, Lantheus Holdings (LNTH) closed at $58.75, indicating a -0.47% shift from the previous trading day.

Lantheus (LNTH) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) an...

Why Lantheus Holdings (LNTH) Outpaced the Stock Market Today
In the most recent trading session, Lantheus Holdings (LNTH) closed at $59.18, indicating a +1.27% shift from the previous trading day.

Why Lantheus Holdings (LNTH) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Is Lantheus (LNTH) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the lat...

Wall Street Analysts See a 44.13% Upside in Lantheus Holdings (LNTH): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 44.1% in Lantheus Holdings (LNTH). While the effectiveness of this highly sought-after metric is questionabl...

Wall Street Analysts See Lantheus Holdings (LNTH) as a Buy: Should You Invest?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm empl...

Lantheus' (LNTH) DEFINITY Approved by FDA for Pediatric Use
Lantheus' (LNTH) receipt of the expanded indication for DEFINITY is likely to address unmet medical needs of pediatric patients.
Related Companies